Koji Ando, Chiaki Inagaki, Yukiya Narita, Mitsuhiro Furuta, Hidekazu Hirano, Taito Esaki, Kenta Murotani, Hisato Kawakami, Eiji Oki, Kei Muro. "Randomized phase II trial evaluating the efficacy of zolbetuximab in the second-line for claudin18.2 positive advanced gastric/EGJ cancer patients previously treated with zolbetuximab and platinum-based chemotherapy (ZELDA trial).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps470